『The Energy Code』のカバーアート

The Energy Code

The Energy Code

著者： Dr. Mike Belkowski
無料で聴く

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

Copyright 2021 All rights reserved. 代替医療・補完医療 衛生・健康的な生活
エピソード
  • MOTS-c: The ‘Exercise Mimetic’ Peptide That Rewires Metabolism, Fat Loss, and Mitochondrial Resilience

    MOTS-c: The ‘Exercise Mimetic’ Peptide That Rewires Metabolism, Fat Loss, and Mitochondrial Resilience
    2026/06/08
    In this peptide-focused Deep Dive, Dr. Mike moves from SS-31 to MOTS-c — one of the most popular mitochondrial-derived peptides for metabolic resilience and mitochondrial wellness. You’ll get a fast, practical primer (what it is + key benefits), then a walkthrough of a review titled “MOTS-c Functionality Prevents Metabolic Disorders,” explaining how MOTS-c acts as a mitochondrial “telegram” to your DNA via retrograde signaling. The episode breaks down MOTS-c’s “exercise mimetic” mechanisms (AMPK activation via AICAR), its reported effects across metabolism, muscle, bone, immune aging, and senescence clearance, and finishes with an actionable playbook for supporting endogenous MOTS-c through mitohormetic lifestyle inputs — and a thoughtful strategy for stacking MOTS-c with SS-31. (Educational content only, not medical advice.) - Article Discussed in Episode: MOTS-c Functionally Prevents Metabolic Disorders - Key Quotes From Dr. Mike: “MOTS-c… helps regulate cellular energy production, metabolic flexibility, and stress adaptation.” “MOTS-c functionally prevents metabolic disorders.” “When the cells are under metabolic stress, MOTS-c… can be rapidly transferred from mitochondria to the nucleus and regulates nuclear gene expression.” “Because MOTS-c is easily destroyed by digestive enzymes, oral delivery remains a significant challenge…” “Some researchers view MOTS-c as a mitochondrial distress signal… mitochondria release more MOTS-c when challenged, not when everything is perfectly comfortable.” “If you want the best of both worlds (for mitochondrial optimization)... stack SS-31 and MOTS-c together.” - Key Points SS-31 and MOTS-c are framed as the “top two” mitochondrial peptides (SS-31 = not mitochondrially-derived but highly mito-targeted; MOTS-c = mito-derived).MOTS-c is positioned as a mitochondrial optimization + metabolic flexibility peptide and an “exercise mimetic.”Core benefits highlighted: energy production, glucose utilization/insulin sensitivity, body composition, endurance/recovery, stress adaptation, longevity support.Big concept: mitochondria aren’t passive; they signal back to the nucleus. MOTS-c can translocate to the nucleus under metabolic stress and regulate gene expression.Mechanism highlighted: MOTS-c disrupts folate–methionine cycle → increases AICAR → activates AMPK → boosts fatty acid oxidation + insulin sensitivity.Review claims include: prevention of diet-induced obesity; possible cardiac protection against remodeling (NRG1–ERBB4 pathway mentioned).Longevity genetics angle: a mitochondrial polymorphism (noted as prevalent in Japanese population) may alter MOTS-c structure and associate with exceptional lifespan.Frailty/bone/muscle: MOTS-c described as inhibiting FOXO1 (muscle wasting signals), supporting myotube formation (STAT3), and reducing osteoclast differentiation (anti-osteoporosis).“Endogenous edge”: as a bioidentical peptide, MOTS-c is framed as potentially less immunogenic than some drugs, but oral delivery is a challenge due to peptide fragility.Practical close: best endogenous stimuli are mitochondrial challenges—exercise, fasting, heat/cold, hypoxia—plus circadian alignment and mitochondrial support nutrients. - Episode timeline 0:00–1:55 — Transition from SS-31 to MOTS-c; why MOTS-c is a “top two” peptide; new format: quick primer before the paper1:55–4:33 — MOTS-c snapshot: what it is + core benefits list (metabolism, insulin sensitivity, fat loss, endurance, longevity)4:33–7:57 — Review intro: mitochondria as control centers; retrograde signaling; MOTS-c as a mitochondrial messenger to DNA7:57–10:44 — “Exercise mimetic” mechanism: folate–methionine cycle → AICAR → AMPK; obesity/metabolic protection examples10:44–12:05 — Longevity genetics: MOTS-c polymorphism + “nature vs nurture” discussion12:05–13:52 — Frailty defense: muscle (FOXO1/STAT3), bone (osteoclast suppression; OPG/RANKL mention)13:52–15:46 — Endogenous/bioidentical angle; immune aging + senescent cell clearance; oral delivery limitations15:46–19:31 — How to boost endogenous MOTS-c: exercise intensity, fasted training nuance, AMPK activators, TRE/IF/CR19:31–24:25 — Cold/heat/circadian alignment + mitochondrial support stack (taurine, urolithin A, CoQ10, PQQ, etc.)24:25–26:10 — “Distress signal” nuance: mitochondria release more MOTS-c when challenged26:10–29:41 — Practical stacking: SS-31 first (engine repair) → add MOTS-c; daily timing suggestions; closing message - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight Labs: Website Instagram BioLight: Website Instagram YouTube Facebook
    続きを読む 一部表示
    31 分
  • SS-31: The Peptide ‘Mitochondrial Shield’ That May Block Parkinson’s Damage at the Source

    SS-31: The Peptide ‘Mitochondrial Shield’ That May Block Parkinson’s Damage at the Source
    2026/06/05
    This is the first dedicated peptide deep dive of The Energy Code — and it starts with arguably the most mitochondrial-centric peptide on the board: SS-31 (Elamipretide). Dr. Mike breaks down a new paper showing how SS-31 may protect neurons in Parkinson’s disease by competing with alpha-synuclein at lipid membranes, slowing toxic aggregation, restoring mitochondrial respiration, and even reducing alpha-synuclein cellular entry. You’ll also hear a key caution: SS-31 appears highly protective at moderate doses, but too much may flip the benefit into harm, reinforcing the “dose makes the medicine” rule in mitochondrial pharmacology. (Educational content only, not medical advice.) - Article Discussed in Episode: Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function - Key Quotes From Dr. Mike: “The future of Parkinson’s therapy may not lie in cleaning up the mess, but rather in providing our neurons with a permanent molecular shield…” “SS-31 acts as a molecular shield protecting the brain’s energy supply…” “SS-31 acts as a molecular bouncer, physically evicting alpha-synuclein from lipid membranes…” “SS-31 substantially prolonged the lag phase of aggregation, essentially stalling the clock on protein buildup.” “These findings underscore the multifaceted protective role of SS-31 against mitochondrial dysfunction caused by alpha synuclein aggregation... SS-31 reversed this decline with a 10 micromolar dose…” - Key Points SS-31 is framed as a mitochondria-first peptide: “restore impaired mitochondrial function” is the headline.Parkinson’s pathology is presented as a cellular power failure inside dopaminergic neurons driven by alpha-synuclein toxicity.SS-31 may act like a “molecular bouncer” — outcompeting alpha-synuclein for anionic lipid membranes and preventing harmful binding/folding.The episode highlights the real-world complication: N-terminal acetylated alpha-synuclein (common in humans) embeds deeper and is harder to displace.SS-31 appears to delay aggregation kinetics (longer “lag phase”) and shift aggregate morphology toward potentially less toxic off-pathway forms.Mitochondrial function was assessed with a Seahorse mito stress test; SS-31 is described as restoring basal/max respiration (at a cited 10 μM dose).Mechanistically, SS-31 is explained as: Cardiolipin binding → supports OXPHOS efficiency/ATP outputROS scavenging (tyrosine residue) → reduces oxidative damage SS-31 may also reduce alpha-synuclein oligomer uptake by altering membrane electrostatics (less negative surface charge).A major warning: very high concentrations (described as >100 μM) may trigger apoptosis / reduce viability.Big-picture: SS-31 supports a “prevention-first” strategy — block the lipid–protein interaction upstream, rather than “cleaning up the mess” later. - Episode timeline 0:00–0:40 — Why peptides are the next major content focus; why SS-31 is the first peptide deep dive0:40–3:55 — Paper intro + “SS-31 restores impaired mitochondrial function” framing; what the show will cover and why it matters3:55–5:44 — Parkinson’s as mitochondrial “power failure”; alpha-synuclein as the driver; SS-31 as a BBB-permeable candidate5:44–6:58 — Takeaway #1: SS-31 as a “molecular bouncer” displacing alpha-synuclein from membranes (dose-dependent)6:58–8:16 — Takeaway #2: N-terminal acetylation makes alpha-synuclein “stickier” and harder to displace (real-human relevance)8:16–9:40 — Takeaway #3: Aggregation kinetics + morphology shifts (stalling the “snowball”)9:40–11:40 — Takeaway #4–#5: Respiration rescue + membrane/cell-entry effects; the dual mechanism (cardiolipin + ROS)11:40–13:20 — Dose caution, wrap-up, and the “designer peptides” future-forward conclusion - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight Labs: Website Instagram BioLight: Website Instagram YouTube Facebook
    続きを読む 一部表示
    15 分
  • The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 1

    The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 1
    2026/06/04
    In this special edition of The Energy Code, Dr. Mike shares a more in-depth discussion on his presentation from Dave Asprey’s BEYOND Biohacking event in Austin: The Energy Code Blueprint: Longevity Starts in the Mitochondria. He introduces BioLight Labs’ initial focus on mitochondrial and longevity peptides, then delivers a thorough foundation on bioenergetics — why “more energy per cell” translates to more vitality, how redox/voltage and electrons relate to inflammation, and why mitochondria act as environmental sensors that drive epigenetics. From there, the episode begins the 6 Pillars of Mitochondrial Wellness, covering Pillar 1 (Energy Production ) —including electron transport chain efficiency and EZ water — and Pillar 2 (Mitogenesis) —with key activators like exercise, fasting, cold exposure, PQQ, urolithin A, and red/near-infrared light. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “The more energy you produce per cell, the more vitality you will have... The less energy you produce per cell, the closer to a state of disease you will be.”“Around 80% of modern diseases are directly tied to mitochondrial dysfunction.”“Any wellness strategy that involves harnessing electrons is inherently anti-aging.”“Epigenetics is rooted in the mitochondria. They sense your environment and then send signals to the cell nucelus, which then turns genes on/off based on those mitochondrial signals."“Cardiolipin… is like the bedrock of mitochondrial function... Many researchers now believe cardiolipin deterioration is one of the central hallmarks of mitochondrial aging.”“SS-31’s mission is to fix and repair and prevent damage to cardiolipin. This makes SS-31 the MOST IMPORTANT peptide for mitochondrial function and anti-aging, from the bioenergetic perspective."“After the age of 30, we typically lose about 1% of energy production annually.”“Mitochondrial decline drives the hallmarks of aging... The future is clearly bioenergetic.” - Key Points ⚡️ Longevity is downstream of bioenergetics: more energy produced per cell → more vitality; less energy → disease trajectory. ⚡️ Mitochondria are upstream of symptoms: dysfunction can precede diagnosis by years/decades. ⚡️ “Healing is Voltage”: redox potential, electron availability, pH, and inflammation are tightly linked. ⚡️ Mitochondria are not just power plants — they are environmental sensors (MIPS) driving epigenetic gene expression via retrograde signaling. ⚡️ Mitohormesis reframes “stress” as a dose-dependent upgrade signal for mitochondria (exercise, fasting, cold/heat, light, key compounds). ⚡️ Cardiolipin is presented as “the mitochondria of the mitochondria,” central to cristae structure, ETC organization, and mitochondrial aging. ⚡️ SS-31 is framed as a top-tier cardiolipin-targeting peptide; MOTS-c, Humanin, SHLP-2 as key mitochondrial-derived peptides. ⚡️ Energy production includes ATP + EZ water: ATP as immediate currency; EZ water as mitochondrial “battery pack” and hydration reserve. ⚡️ Red and near-infrared light are positioned as major tools to expand EZ water and support mitochondria across multiple pillars. ⚡️ The presentation tees up a “6 pillars” framework and promises a next episode continuation (pillars 3–6 + applications). - Episode timeline 00:00–01:55 — Special edition + Beyond Biohacking context; BioLite Labs intro (peptides focus) 01:55–04:52 — Talk format notes + offer to email slides as a resource 04:52–08:54 — Overview: bioenergetics → 6 pillars → optimization strategies → “day in the life” blueprint 08:55–11:02 — Bioenergetics foundation: “more energy per cell = more vitality” (Doug Wallace framing) 11:03–13:50 — Mitochondria as root cause: cells → tissues → organs → systems; symptoms appear late 13:51–17:32 — Voltage/redox: electrons, pH, inflammation; examples (sunlight, grounding, electron-rich strategies) 17:33–19:04 — “Anti-aging via electrons”: shared thread across many wellness strategies 19:07–21:21 — Mitochondria as environmental sensors (MIPS) + retrograde signaling → epigenetics 21:23–24:42 — Mitohormesis: what doesn’t kill mitochondria makes them stronger; key stressors/benefits 24:45–31:56 — Cardiolipin deep dive: cristae structure, fragility to oxidative stress, downstream consequences; SS-31 spotlight 31:57–35:55 — Mitochondrial lens of aging: “energy cliff” concept; mitochondrial decline drives aging hallmarks 36:39–38:00 — “Future is bioenergetic”: move from managing decline to engineering resilience 38:01–40:10 — Six pillars introduced: energy, biogenesis, mitophagy, dynamics, ROS protection, light 40:11–46:22 — Pillar 1 (part 1): ETC mechanics; complex I/III issues; methylene blue + taurine note 46:23–51:25 — Pillar 1 (part 2): EZ ...
    続きを読む 一部表示
    1 時間 2 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません